Cargando…
Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate
Glycolytic intermediary metabolites such as fructose-1,6-bisphosphate can serve as signals, controlling metabolic states beyond energy metabolism. However, whether glycolytic metabolites also play a role in controlling cell fate remains unexplored. Here, we find that low levels of glycolytic metabol...
Autores principales: | Wu, Yu-Qing, Zhang, Chen-Song, Xiong, Jinye, Cai, Dong-Qi, Wang, Chen-Zhe, Wang, Yu, Liu, Yan-Hui, Li, Yiming, Wu, Jian, Wu, Jianfeng, Lan, Bin, Wang, Xuefeng, Chen, Siwei, Cao, Xianglei, Wei, Xiaoyan, Hu, Hui-Hui, Guo, Huiling, Yu, Yaxin, Ghafoor, Abdul, Xie, Changchuan, Wu, Yaying, Xu, Zheni, Zhang, Cixiong, Zhu, Mingxia, Huang, Xi, Sun, Xiufeng, Lin, Shu-Yong, Piao, Hai-Long, Zhou, Jianyin, Lin, Sheng-Cai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624847/ https://www.ncbi.nlm.nih.gov/pubmed/37726403 http://dx.doi.org/10.1038/s41422-023-00874-4 |
Ejemplares similares
-
Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer
por: Unterlass, Judith E., et al.
Publicado: (2016) -
ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC
por: Wang, Huihui, et al.
Publicado: (2023) -
Structure–Activity Relationships (SARs) of α-Ketothioamides as Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)
por: Spillier, Quentin, et al.
Publicado: (2020) -
Identification of Novel Natural Inhibitors to Human 3-Phosphoglycerate Dehydrogenase (PHGDH) for Cancer Treatment
por: Sadiqa, Ayesha, et al.
Publicado: (2022) -
The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK
por: Zhang, Chen-Song, et al.
Publicado: (2022)